Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Peace Sandy on 2024-2-12

Curated date: 2023/12/12

Curator: Yjung24

Revision editor(s): Yjung24, Peace Sandy

Subjects

Location of subjects
Russian Federation
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Ulcerative colitis colitis ulcerative,Colitis, Ulcerative,Left-sided ulcerative (chronic) colitis,Left-sided ulcerative colitis,left-sided ulcerative colitis,Other ulcerative colitis,Other ulcerative colitis (disorder),UC - ulcerative colitis,ulcerative colitis,ulcerative colitis (disease),ulcerative colitis (disorder),Ulcerative colitis, unspecified,ULCERATVE COLITIS UNSPCF,Ulcerative colitis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Ulcerative colitis
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with ulcerative colitis
Group 0 sample size Number of subjects in the control (unexposed) group
10
Group 1 sample size Number of subjects in the case (exposed) group
10
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
NIL

Lab analysis

Sequencing type
PCR
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Ion Torrent

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
raw counts
Statistical test
DESeq2
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No


Signature 1

Reviewed Marked as Reviewed by Peace Sandy on 2024-2-12

Curated date: 2023/12/12

Curator: Yjung24

Revision editor(s): Yjung24, Peace Sandy

Source: Figure 2 and Figure 3

Description: Quantitative changes in the bacteria generic composition of the intestinal microbiome in patients with ulcerative colitis relative to control group.

Changes in species composition of intestinal microbiome in patients with ulcerative colitis relative to control group (∗Pvalue≤0.05, ∗∗Pvalue≤0.01, ∗∗∗Pvalue≤0.001).

Abundance in Group 1: increased abundance in Ulcerative colitis

NCBI Quality ControlLinks
Butyrivibrio
Cedecea
Faecalibacterium
Haemophilus
Lachnospira
Lachnospiraceae bacterium NK4A136
Negativibacillus
Olsenella
Peptostreptococcus
Prevotella
Phocaeicola coprocola
Phascolarctobacterium succinatutens
Dialister succinatiphilus
Sutterella wadsworthensis
Faecalibacterium prausnitzii

Revision editor(s): Yjung24, Peace Sandy

Signature 2

Reviewed Marked as Reviewed by Peace Sandy on 2024-2-12

Curated date: 2023/12/12

Curator: Yjung24

Revision editor(s): Yjung24, Peace Sandy

Source: Figure 2 and Figure 3

Description: Quantitative changes in the bacteria generic composition of the intestinal microbiome in patients with ulcerative colitis relative to control group.

Changes in species composition of intestinal microbiome in patients with ulcerative colitis relative to control group (∗Pvalue≤0.05, ∗∗Pvalue≤0.01, ∗∗∗Pvalue≤0.001).

Abundance in Group 1: decreased abundance in Ulcerative colitis

NCBI Quality ControlLinks
Brevundimonas
Butyricimonas
Coprobacter
Cutibacterium
Eisenbergiella
Falsochrobactrum
Fusicatenibacter
Lactococcus
Leuconostoc
Yersinia
unclassified Lachnospiraceae
Fusicatenibacter saccharivorans

Revision editor(s): Yjung24, Peace Sandy